Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meclizine Plasma Levels in Seasickness Responders vs Non-responders
NCT04482985Phase 4Unknown
- Sponsor
- Israel Defense Forces Medical Corps
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of meclizine in motion sickness, sponsored by Israel Defense Forces Medical Corps. Status: unknown.
02
Drugs
meclizine
03
Conditions
motion sickness
Beyond the preview
Go deeper on NCT04482985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04482985.